Coming Soon: An LDL-Lowering Drug with Few Side Effects
Bempedoic acid may be an alternative for patients who canít take statins.
Any day now the U.S. Food & Drug Administration is likely to approve a novel cholesterol-lowering agent called bempedoic acid. It is as effective as statins in reducing LDL cholesterol and C-reactive protein (CRP), a marker of inflammation associated with increased risk of heart attack and stroke. However, bempedoic acid does not cause the muscle-related side effects that lead some people to stop taking statins.